We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$124B
AUM Growth
+$12.6B
Cap. Flow
+$4.01B
Cap. Flow %
3.23%
Top 10 Hldgs %
24.28%
Holding
4,396
New
293
Increased
2,114
Reduced
1,559
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 15.45%
2 Financials 8.54%
3 Healthcare 8.18%
4 Consumer Discretionary 6.58%
5 Industrials 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPL
3826
CALL
PPL Corp
PPL
$26.6B
$113K ﹤0.01%
64,800
PRVB
3827
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$112K ﹤0.01%
20,000
+25
+0.1% +$159
ETAC
3828
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
$112K ﹤0.01%
11,400
-2,585
-18% -$25.4K
WRAP icon
3829
Wrap Technologies
WRAP
$105M
$110K ﹤0.01%
28,100
-3,000
-10% -$15.8K
AROC icon
3830
Archrock
AROC
$5.79B
$109K ﹤0.01%
14,513
+1,161
+9% +$9.34K
AIRG icon
3831
Airgain
AIRG
$70.9M
$108K ﹤0.01%
+10,200
New +$110K
IPOF
3832
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$108K ﹤0.01%
10,633
-40
-0.4% -$411
AMRN
3833
Amarin Corp
AMRN
$297M
$106K ﹤0.01%
1,569
-23
-1% -$1.9K
CMU
3834
DELISTED
MFS High Yield Municipal Trust
CMU
$106K ﹤0.01%
23,415
NUVB icon
3835
Nuvation Bio
NUVB
$2.24B
$106K ﹤0.01%
12,460
+1,000
+9% +$9.19K
OXSQ icon
3836
Oxford Square Capital
OXSQ
$150M
$106K ﹤0.01%
26,094
-12,000
-32% -$49.9K
SOL
3837
DELISTED
Emeren Group
SOL
$104K ﹤0.01%
17,404
+914
+6% +$6.54K
IAG icon
3838
IAMGOLD
IAG
$10.4B
$102K ﹤0.01%
+32,729
New +$96.1K
VUZI icon
3839
Vuzix
VUZI
$221M
$102K ﹤0.01%
11,797
+917
+8% +$9.91K
PATI
3840
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$102K ﹤0.01%
12,669
+1,700
+15% +$18.9K
ADAM
3841
Adamas Trust
ADAM
$920M
$101K ﹤0.01%
6,814
-1,676
-20% -$27.5K
COMP icon
3842
Compass
COMP
$9.74B
$99K ﹤0.01%
+10,935
New +$120K
TIGR
3843
UP Fintech Holding
TIGR
$842M
$99K ﹤0.01%
20,086
-40,230
-67% -$282K
BHIL
3844
DELISTED
Benson Hill, Inc.
BHIL
$99K ﹤0.01%
+387
New +$93.5K
HUYA
3845
Huya Inc
HUYA
$565M
$98K ﹤0.01%
14,095
-1,000
-7% -$8.28K
BWAY
3846
Brainsway
BWAY
$600M
$97K ﹤0.01%
+25,200
New +$100K
ICAD
3847
DELISTED
iCAD Inc
ICAD
$97K ﹤0.01%
13,419
-1,300
-9% -$11.6K
IMMR icon
3848
Immersion
IMMR
$249M
$96K ﹤0.01%
16,807
+907
+6% +$5.97K
TME icon
3849
Tencent Music
TME
$14.3B
$96K ﹤0.01%
13,955
-16,185
-54% -$119K
FBIO icon
3850
Fortress Biotech
FBIO
$87.4M
$95K ﹤0.01%
2,521

Similar funds

Raymond James & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Raymond James & Associates held 4,396 positions worth $124B, up 11% from $111B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.01B of net new capital in Q4 2021, opening 293 new positions and adding to 2,114 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI All Country Asia ex Japan ETF, an estimated $80M trimmed.

  • Raymond James & Associates's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2021, an estimated $212M increase.
  • Raymond James & Associates's biggest Q4 2021 reduction was iShares MSCI All Country Asia ex Japan ETF, cutting an estimated $80M.
  • Raymond James & Associates fully exited Kansas City Southern in Q4 2021, selling an estimated $80.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $124B portfolio in Q4 2021.
  • Raymond James & Associates opened 293 new positions and closed 268 in Q4 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $124B.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.